Biology can be programmed like software. That's not a metaphor — it's literally what we do.

Every organism we engineer adds to our codebase. The platform gets better with every project.

We went from $24 billion valuation to $1 billion. The science is real. The revenue timeline wasn't.

Tom Knight wrote the foundational paper on synthetic biology at MIT. We're his commercial legacy.

We were the first biotech in Y Combinator. People thought we were insane. We raised $2.8 billion.

TSMC manufactures chips to spec. Ginkgo manufactures organisms to spec. Same model, different substrate.